Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIMBOW versus FOSTAIR crossover study in moderate to severe COPD
2018-003113-17Phase 4Completed
- Sponsor
- Medicines Evaluation Unit
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium and beclometasone dipropionate + formoterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Medicines Evaluation Unit. Primary endpoint: Change in FEV1 from predose Day 1. Started Oct 2018; status: completed.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrroniumbeclometasone dipropionate + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2018-003113-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003113-17.